| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |